OPKO director granted 60,000 stock options
OPKO HEALTH, INC. director Richard C. Pfenniger Jr. received a grant of stock options representing 60,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OPKO HEALTH, INC. director Richard C. Pfenniger Jr. received a grant of stock options representing 60,000 shares of common stock. The options have an exercise price of $1.42 per share, become exercisable on June 18, 2027, and expire on June 17, 2036. After this award, he holds 60,000 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 60,000 | $0.00 | $0.00 |
Key Figures
Key Terms
Stock Option (Right to Buy) financial
derivative securities financial
exercise price financial
expiration date financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OPKO (OPK) director Richard C. Pfenniger Jr. report on this Form 4?
How many OPKO stock options were granted to Richard C. Pfenniger Jr.?
What is the exercise price of the OPKO options granted to Richard C. Pfenniger Jr.?
When do Richard C. Pfenniger Jr.’s OPKO stock options become exercisable and when do they expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.